B., Fink-Jensen, A., Wortwein, G., Seeley, R
Another 16-week phase 2 trial in subjects with T2D and BMI 2550 kg/m 2 treated with survodutide 0.3, 0.9, 1.8, 2.7 mg weekly, 1.2 mg and 1.8 mg twice weekly, compared to semaglutide 1.0 mg weekly or placebo shows mean HbA1c percentage point reductions of 0.9, 1.5, 1.7, 1.6, 1.6, 1.7, 1.5, and 0.2, respectively, as well as mean body weight reductions significantly greater than placebo at all treatment doses, the highest being 8.7% for the 1.8 mg twice a week dose (97)
Patients with documented improvement more often experienced larger reductions in BMI compared with those with no change or worsening
Try interval training : When youre ready to up the intensity, alternate between brisk walking and jogging to burn more calories
3,000 mg per serving to convert fat into energy for peak performance